TMDX CLASS ACTION ALERT: Lose Money when TransMedics Group, Inc. Plummeted 30%? Contact BFA Law about the Class Action Lawsuit
If you invested in TransMedics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc.
Investors have until April 15, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased TransMedics securities. The case is pending in the U.S. District Court for the District of Massachusetts and is captioned Jewik v. TransMedics Group, Inc. et al, No. 25-cv-10385.
Why was TransMedics Sued for Fraud?
TransMedics is a commercial-stage medical technology company. The Company's 'Organ Care System' ('OCS') is a medical device that keeps donor organs viable before transplant by replicating many aspects of the organ's natural living and functioning environment outside of the human body.
The complaint alleges that TransMedics misrepresented that its business was driven by kickbacks, fraudulent overbilling, and coercive tactics. The complaint further alleges that the company misrepresented that it engaged in unsafe practices involving OCS, hid safety issues, and generally lacked safety oversight.
The Stock Declines as the Truth is Revealed
On February 21, 2024, U.S. Representative and member of the House Committee on Oversight and Accountability Paul Gosar issued a letter accusing the Company of misconduct including overcharging for OCS and misappropriating corporate resources. This news allegedly caused the price of TransMedics stock to decline approximately 4% over two trading days, from $86.99 per share on February 21, 2024 to $83.14 per share on February 23, 2024.
On December 2, 2024, TransMedics announced the resignation of its CFO from that role and narrowed its financial outlook for 2024. Then, on January 10, 2025, Scorpion Capital issued a research report explaining that TransMedics's growth was fueled by an anti-competitive scheme that included kickbacks to medical providers to use the company's products and that TransMedics further boosted growth by operating an organ trafficking scheme, engaged in widespread billing fraud, and promoted off-label use. The publication of the Scorpion Capital report caused the price of TransMedics stock to decline an additional 5%, from $72.55 per share on January 8, 2025 to $68.81 per share on January 10, 2025.
Click here for more information: .
What Can You Do?
If you invested in TransMedics you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
Or contact:
212-789-3619
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs' Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
27 minutes ago
- USA Today
US stock futures flat ahead of big box retailer results
U.S. stock futures are flat after a listless start to the week as investors stayed sidelined ahead of quarterly results from big box retailers and a conference of global financial leaders later this week. Discount giants Walmart and Target and home improvement company Lowe's are slated to report around midweek. Home Depot is due before the market opens. These earnings can provide a window into how tariffs are affecting companies and consumer spending. Federal Reserve Chair Jerome Powell is set to give a speech at the end of the week at the annual Jackson Hole Economic Symposium of global central bankers and finance chiefs. Investors will be looking for hints Powell may be done waiting to see tariff effects before cutting rates again. The CME FedWatch tool that shows the likelihood that the Fed will change rates at each policy meeting based on market trading suggests a nearly 84% chance of the Fed easing rates in September. Before Powell's speech, investors will get a glimpse midweek of the dissents at the last Fed meeting. Fed governors Christopher Waller and Michelle Bowman voted against the central bank's decision to keep rates unchanged between 4.25%-4.50% last month. It was the first time since 1993 that two governors dissented. At 6:10 a.m. ET, futures linked to the blue-chip Dow added 0.03%, while broad S&P 500 futures slipped -0.06% and tech-laden Nasdaq futures fell -0.05%. Corporate news Medora Lee is a money, markets and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday morning.
Business Wire
27 minutes ago
- Business Wire
GuidePoint Security Named to the Inc. 5000 List for the Tenth Consecutive Time
RESTON, Va.--(BUSINESS WIRE)-- GuidePoint Security, a cybersecurity solutions leader enabling organizations to make smarter decisions and minimize risk, today announced its inclusion on the Inc. 5000, Inc.'s annual list of the fastest-growing private companies in America. GuidePoint Security's growth is driven by an exceptional team of cybersecurity experts and an unwavering commitment to delivering top-tier tailored solutions. The list provides a data-driven snapshot of the most successful companies within the economy's most dynamic segment: its independent, entrepreneurial businesses. This year, GuidePoint Security ranks No. 2,470 and joins the Inc. 5000 10X Club, a rare feat that few organizations have achieved. 'We're honored to be named to the Inc. 5000 for the tenth consecutive year,' said Michael Volk, Chairman and CEO of GuidePoint Security. 'GuidePoint Security's growth is driven by an exceptional team of cybersecurity experts and an unwavering commitment to delivering top-tier tailored solutions. This recognition underscores our customer-first approach and marks an exciting milestone as we move into the next phase of our journey.' This year's Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure and a fluctuating labor market. Among the top 500 companies on the list, the median three-year revenue growth rate reached 1,552 percent, and those companies have collectively added more than 48,678 jobs to the U.S. economy over the past three years. 'Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company's tenacity and clarity of vision,' says Mike Hofman, editor-in-chief of Inc. 'These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn't just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy.' This ranking follows a record-breaking first half for GuidePoint Security, fueled by strategic investments to fuel innovation and drive expansion. Over the past year, the company has surpassed 1,000 employees, opened three new offices—including a new global headquarters—and introduced new capabilities in cloud security, identity and access management, and AI/ML risk. GuidePoint has also expanded its 'as-a-service' portfolio with offerings such as Phishing-as-a-Service, while maintaining double-digit growth and industry-leading customer satisfaction and retention rates. For the full list, company profiles, and a searchable database by industry and location, visit: For more information on GuidePoint Security, please visit About GuidePoint Security GuidePoint Security provides trusted cybersecurity expertise, solutions, and services that help organizations make better decisions that minimize risk. Our experts act as your trusted advisor to understand your business and challenges, helping you through an evaluation of your cybersecurity posture and ecosystem to expose risks, optimize resources and implement best-fit solutions. GuidePoint's unmatched expertise has enabled 40% of Fortune 500 companies and more than half of the U.S. government cabinet-level agencies to improve their security posture and reduce risk. Learn more at More about Inc. and the Inc. 5000 Methodology Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. About Inc. Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit
Business Wire
27 minutes ago
- Business Wire
Hercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.
SAN MATEO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) ('Hercules' or the 'Company'), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. ('KBRA') has affirmed Hercules' investment grade corporate and credit rating of BBB+. KBRA issued a statement announcing the affirmation of the rating and stable outlook, as well as its underlying analysis. The affirmed BBB+ rating reflects the Company's diversified investment portfolio with a focus on senior secured first lien venture debt investments in the technology and life sciences sectors, solid 20+ year operating record, including during the global financial crisis, and appropriate leverage metrics. The Company's solid credit quality has benefited from the Company's robust risk management and solid investment team with years of experience in the venture capital space. Furthermore, the ratings are supported by the Company's proven access to capital markets, diversified funding mix and high proportion of unsecured debt to total debt outstanding allowing for solid protection for noteholders. About Hercules Capital, Inc. Hercules Capital, Inc. (NYSE: HTGC) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broad variety of technology and life sciences industries. Since inception (December 2003), Hercules has committed more than $23 billion to over 690 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. Companies interested in learning more about financing opportunities should contact info@ or call 650.289.3060. Hercules, through its wholly owned subsidiary business, Hercules Adviser LLC (the 'Adviser Subsidiary'), also maintains an asset management business through which it manages investments for external parties ('Adviser Funds'). The Adviser Subsidiary is registered as an investment adviser under the Investment Advisers Act of 1940. Hercules' common stock trades on the New York Stock Exchange (NYSE) under the ticker symbol 'HTGC.' In addition, Hercules has one retail bond issuance of 6.25% Notes due 2033 (NYSE: HCXY). Forward-Looking Statements This press release may contain 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. We may use words such as 'anticipates,' 'believes,' 'expects,' 'intends,' 'will,' 'should,' 'may' and similar expressions to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and should not be relied upon in making any investment decision. Such statements are based on currently available operating, financial and competitive information and are subject to various risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations. While we cannot identify all such risks and uncertainties, we urge you to read the risks discussed in our Annual Report on Form 10-K and other materials that we publicly file with the Securities and Exchange Commission. Any forward-looking statements made in this press release are made only as of the date hereof. Hercules assumes no obligation to update any such statements in the future.
